Tower Research Capital LLC (Trc) Xenetic Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.27 - $5.75 $90 - $1,932	-336 Reduced 2.87%	11,354 $3,000
Q3 2022 Nov 10, 2022	SELL	$0.59 - $5.57 $1,586 - $14,977	-2,689 Reduced 18.7%	11,690 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.6 - $1.14 $7,545 - $14,336	12,576 Added 697.5%	14,379 $12,000
Q1 2022 May 12, 2022	BUY	$0.88 - $1.37 $1,565 - $2,437	1,779 Added 7412.5%	1,803 $2,000
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.08 $3,785 - $6,200	-2,981 Reduced 99.2%	24 $0
Q3 2021 Nov 15, 2021	BUY	$1.73 - $5.3 $5,198 - $15,926	3,005 New	3,005 $6,000

Ticker XBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,166,600
Market Cap $64.6M
Description
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.